Compare · head to head
Fleury vs Sarana Meditama Metropolitan
Fleury ranks higher overall — 360 rank 95 vs 10.
Fleury leads on Value (71 vs 34), Quality (74 vs 37), Growth (58 vs 38), Safety (57 vs 49) and Sentiment (46 vs 40).
Ranks as of 2026-06-12 · 1–100 vs true peers. Higher is better.
| Compare | ||
|---|---|---|
| Profile | ||
| Country | Brazil | Indonesia |
| Sector | Health Care | Health Care |
| Industry | Health Care Providers & Services | Health Care Providers & Services |
| Size | Large | Small |
| ISIN | BRFLRYACNOR5 | ID1000126303 |
| Last update | 2026-04-02 | 2026-04-02 |
| History | ||
| 360 (V1) since 2023 | ||
| Ranks | ||
| 360 | 95 | 10 |
| Value | 71 | 34 |
| Quality | 74 | 37 |
| Growth | 58 | 38 |
| Safety | 57 | 49 |
| Sentiment | 46 | 40 |
| Quality details | ||
| Profitability | 68 | 17 |
| Cash Truth | 79 | 56 |
Fleury vs Dr. Lal PathLabsFleury vs OdontoprevFleury vs Diagnósticos da AméricaFleury vs Hapvida Participações e InvestimentosAdd a third stock →
Full analyses: Fleury · Sarana Meditama Metropolitan
Make Sense of the Ranks
Every rank runs 1–100 against true peers. Higher is always better.
360° View
1 · Watch OutGood· 100
Value
1 · ExpensiveGood Value· 100
Quality
1 · Weak FundamentalsHigh Quality· 100
Growth
1 · Tough TimesHigh Growth· 100
Safety
1 · High LeverageWell-Financed· 100
Sentiment
1 · SkepticismPositive· 100